QUARTERLY FOCUS ISSUE: HEART RHYTHM DISORDERS: VIEWPOINT
Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial InfarctionThe Results Are Not Shocking
Jeffrey J. Goldberger, MD* and
Rod Passman, MD, MSCE
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Manuscript received April 13, 2009;
revised manuscript received July 16, 2009,
accepted August 10, 2009.
* Reprint requests and correspondence: Dr. Jeffrey J. Goldberger, Northwestern University Feinberg School of Medicine, 251 East Huron Street, Feinberg 8-503, Chicago, Illinois 60611 (Email: j-goldberger{at}northwestern.edu).
The risk of sudden death is highest early after myocardial infarction (MI) and progressively declines over the ensuing 6 to 12 months. Nevertheless, several randomized clinical trials have failed to show a survival benefit for implantable cardioverter-defibrillators when implanted early after MI in high-risk patients. The etiology of this acute MI–sudden cardiac death paradox is unclear, but may be related to the changing nature of the substrate over the several month period after acute MI. Further investigation is needed to delineate the actual causes of death in the early post-MI period and which interventions can be implemented to reduce the increased rate of sudden death that is observed.
Key Words: myocardial infarction sudden death implantable defibrillator
|
Abbreviations and Acronyms
| | ICD = implantable cardioverter-defibrillator | | MI = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
L. M. Fleck
Just Caring: Defining a Basic Benefit Package
J Med Philos,
December 13, 2011;
(2011)
jhr052v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kadish and J. Goldberger
Selecting Patients for ICD Implantation: Are Clinicians Choosing Appropriately?
JAMA,
January 5, 2011;
305(1):
91 - 92.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-R. Arntz
Chapter 2 Sudden cardiac death: epidemiology and prevention
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Scirica, E. Braunwald, L. Belardinelli, C. M. Hedgepeth, J. Spinar, W. Wang, J. Qin, E. Karwatowska-Prokopczuk, F. W. A. Verheugt, and D. A. Morrow
Relationship Between Nonsustained Ventricular Tachycardia After Non-ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial
Circulation,
August 3, 2010;
122(5):
455 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|